Literature DB >> 20337945

G protein beta3 subunit, interleukin-10, and tumor necrosis factor-alpha gene polymorphisms in Koreans with irritable bowel syndrome.

H-J Lee1, S-Y Lee, J E Choi, J H Kim, I-K Sung, H S Park, C J Jin.   

Abstract

BACKGROUND: The association between irritable bowel syndrome (IBS) based on Rome III criteria and G protein beta3 subunit (GNB3), interleukin (IL)-10, and tumor necrosis factor (TNF)-alpha gene polymorphisms is uncertain.
METHODS: Case and control subjects were recruited from Korean visitors to the Health Promotion Center and Digestive Disease Center for gastrointestinal endoscopy. G protein beta3 subunit, IL-10, and TNF-alpha gene polymorphisms were genotyped using a polymerase chain reaction-based method. Multifactor dimensionality reduction (MDR) analysis was used to assess gene-gene interactions. KEY
RESULTS: Genotype and allele frequencies of GNB3 showed marginal significance between the healthy controls and IBS patients (chi(2) = 5.92, P = 0.052; chi(2) = 3.76, P = 0.053). G protein beta3 subunit T allele was more strongly correlated with IBS with constipation (12 of constipation-dominant type and 31 of mixed type) than with 51 diarrhea-dominant type and 88 normal subjects (chi(2) = 13.91, P = 0.008). Multifactor dimensionality reduction analysis revealed that there were no significant interactions of GNB3, IL-10, and TNF-alpha gene variants with susceptibility to IBS (P > 0.05). CONCLUSIONS & INFERENCES: The results suggest that GNB3 825T allele might be associated with IBS with constipation in Koreans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20337945     DOI: 10.1111/j.1365-2982.2010.01496.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  17 in total

Review 1.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors:  Michael Camilleri; David A Katzka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

Review 2.  Association of interleukin-10 polymorphisms with risk of irritable bowel syndrome: a meta-analysis.

Authors:  Shan-Yu Qin; Hai-Xing Jiang; Dong-Hong Lu; You Zhou
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

3.  Serotonin transporter and G protein beta 3 subunit gene polymorphisms in Greeks with irritable bowel syndrome.

Authors:  T Markoutsaki; T Karantanos; M Gazouli; N P Anagnou; S D Ladas; D G Karamanolis
Journal:  Dig Dis Sci       Date:  2011-05-11       Impact factor: 3.199

Review 4.  Genetic polymorphism in pathogenesis of irritable bowel syndrome.

Authors:  Cynthia K Y Cheung; Justin C Y Wu
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 5.  Molecular basis of the irritable bowel syndrome.

Authors:  Anna Vaiopoulou; Georgios Karamanolis; Theodora Psaltopoulou; George Karatzias; Maria Gazouli
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 6.  Genetics of human gastrointestinal sensation.

Authors:  M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2013-04-17       Impact factor: 3.598

7.  No association of G-protein beta polypeptide 3 polymorphism with irritable bowel syndrome: evidence from a meta-analysis.

Authors:  Zhi-Gang Pan; Chen Xiao; Dong-Xing Su
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

Review 8.  Genetic epidemiology of irritable bowel syndrome.

Authors:  Jasbir Makker; Sridhar Chilimuri; Jonathan N Bella
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

9.  Is There Enough Evidence for the Association of GNβ3 C825T Polymorphism With Functional Dyspepsia and Irritable Bowel Syndrome?: Author's Reply.

Authors:  Kwang Jae Lee
Journal:  J Neurogastroenterol Motil       Date:  2012-07-10       Impact factor: 4.924

10.  Is There Enough Evidence for the Association of GNβ3 C825T Polymorphism With Functional Dyspepsia and Irritable Bowel Syndrome?

Authors:  Moo In Park
Journal:  J Neurogastroenterol Motil       Date:  2012-07-10       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.